Immune-Mediated Hemolytic Anemia
-
p.1 p.1
Immune-Mediated Hemolytic Anemia
Remo Lobetti, BVSc, MMedVet (Med), Ph.D. Dipl ECVIM (Int Med)p.1 -
p.2 p.2
Introduction
>Destruction or phagocytosis of RBC
>Primary vs. secondary
>Dog - common and often fatal
>Cat - uncommonp.2 -
p.3 p.3
Pathophysiology
>Red cell antibodies
>Primary/idiopathic IMHA:
>Normal erythrocytes
>Secondary IMHA:
>Antigenically altered erythrocytes:
>Exposure of hidden RBC antigens
>Cross reaction with new antigens
>Non-specific antibody reactionp.3 -
p.4 p.4
Image
p.4 -
p.5 p.5
Immunoglobulins
>IgG and/or IgM antibodies
>IgG antibodies:
>Cannot directly agglutinate RBC unless a large
amount of antibody is present
>Phagocytosed occurs in spleen
>IgM antibodies:
>Direct agglutination of RBC
>IgM can detach after complement activation
and bind to other RBC
>Phagocytosed occurs in liverp.5 -
p.6 p.6
Complement
>Binding of complement proteins to RBC
>Complement activation:
>Intravascular lysis
>Extravascular lysis
>Spherocytesp.6 -
p.7 p.7
Other Factors
>“Membrane attack complex’:
>CI (serine protease)
>Associated with complement cascade
>Damages RBC membrane:
>Influx of water and electrolytes
>Cell swelling
>Lysis
>Phagocytosis by splenic macrophagesp.7 -
p.8 p.8
Antibody
Complement
RBC membrane antigen
C3bR
FCR
Macrophage
Spherocyte
Phagocytosed membrane fragmentp.8 -
p.9 p.9
Primary IMHA
>Canine:
>Young to middle-aged
>Female spayed
>Specific breeds
>Feline:
>Young
>Malep.9 -
p.10 p.10
Primary IMHA (Cont.)
>No obvious underlying cause
>True idiopathic AIHA
>Can be associated with:
>Evans syndrome
>SLEp.10 -
p.11 p.11
Secondary IMHA Aetiology
>Infectious
>Drugs
>Toxins
>Neoplasiap.11 -
p.12 p.12
Secondary IMHA Infectious
>FeLV
>Bacterial endocarditis
>Ehrlichiosis
>Leptospirosis
>Hemoplasmas
>Babesiosis
>Chronic bacterial infections
>Systemic fungal infections
>Helminthsp.12 -
p.13 p.13
Secondary IMHA Drugs
>Penicillin
>Cephalosporin
>NSAIDs
>Potentiated sulphonamides
>Endogenous estrogen
>Vaccines
>Blood transfusionsp.13 -
p.14 p.14
Secondary IMHA Toxins
>Beestings
>Snake bitesp.14 -
p.15 p.15
Secondary IMHA Neoplasia
>Lymphoma
>Leukemia
>Hemangiosarcomap.15 -
p.16 p.16
Diagnostic Approach
>History and clinical examination
>Urine and fecal analyses
>Hematology
>Serum biochemistryp.16 -
p.17 p.17
History and Clinical Signs
>History:
>Recent vaccinations
>Exposure tick/parasites
>Recent therapy
>Clinical:
>Anemia
>Hemoglobinuria
>Fever
>Splenomegalyp.17 -
p.18 p.18
Image
p.18 -
p.19 p.19
Urine and Fecal Analyses
>Concentrated specific gravity
>Dipstick
>Bilirubinuria
>Hemoglobinuria
>Proteinuria
>Sediment
>RTE cells
>Fecalp.19 -
p.20 p.20
Image
p.20 -
p.21 p.21
Image
p.21 -
p.22 p.22
Image
p.22 -
p.23 p.23
Hematological Findings
>Dependent on onset:
>Inappropriate anemia
>Regenerative anemia
>Spherocytosis
>Inflammatory leukogram
>Thrombocytopeniap.23 -
p.24 p.24
Image
p.24 -
p.25 p.25
Image
p.25 -
p.26 p.26
Image
p.26 -
p.27 p.27
Haematological Findings (Cont.)
>Positive in-saline-agglutination
>Positive Coombs’ test
>Evidence of DIC:
>Prolonged PT/PTT
>Elevated FDP
>Elevated d-dimersp.27 -
p.28 p.28
Image
p.28 -
p.29 p.29
Image
p.29 -
p.30 p.30
Antibody-mediated agglutination
Saline added
Gross granularity
Persistent granularity Positive test result
Rouleaux formation
Saline added
Gross granularity
Loss of granularity Negative test resultp.30 -
p.31 p.31
Image
p.31 -
p.32 p.32
Fc Receptor
Removal of a piece of RBC membrane
Spherocyte
Normal discoid
RBCsp.32 -
p.33 p.33
Biochemistry
> Elevated liver enzymes (ALP/ALT)
> Bilirubinemia
> Elevated urea with normal creatinine
> Elevated proteinsp.33 -
p.34 p.34
Diagnostic Approach (Cont.)
>Radiographs
>Abdominal ultrasonography
>Echocardiography
>Urine and blood culture
>Serology and/or PCR
>Bone marrow aspirate/biopsyp.34 -
p.35 p.35
Diagnostic imaging
> Thoracic radiographs
> Spinal radiographs
> Ultrasonography
> Echocardiographyp.35 -
p.36 p.36
Image
p.36 -
p.37 p.37
Image
p.37 -
p.38 p.38
Image
p.38 -
p.39 p.39
Image
p.39 -
p.40 p.40
Image
p.40 -
p.41 p.41
Image
p.41 -
p.42 p.42
Summary
>Exclude secondary IMHA before diagnosing primary IMHA
>Early ’80’s – 90% primary IMHA
>Now – 60% primary IMHAp.42 -
p.43 p.43
Therapy
>Treat primary cause
>Immunosuppressive therapy:
>Short course with secondary IMHA
>Prolonged course with primary IMHA
>Supportive therapyp.43 -
p.44 p.44
Corticosteroids
>Decrease Ab production
>Decrease Fc-mediated destruction of red cell
>Prednisone - 2mg/kg bidp.44 -
p.45 p.45
Cyclophosphamide
>Block DNA and RNA synthesis
>Suppress Ab production
>Suppress lymphocytes
>2mg/kg oid 4 days per weekp.45 -
p.46 p.46
Cyclosporine
>T-cell suppression
>Inhibition of immune response by decreased production of IL-2
>5mg/kg bidp.46 -
p.47 p.47
Azathioprine
>Suppress T-cell function
>2 mg/kg oidp.47 -
p.48 p.48
Danazol
>Reduces red cell fragility
>Block Fc-receptors
>5-10 mg/kg bidp.48 -
p.49 p.49
Intra-venous Immunoglobulins
>Block/saturate Fc-receptors
>0.5-1.5 g/kg IV over 6 hoursp.49 -
p.50 p.50
Other Drugs
>Mycophenolate
>Leflunomidep.50 -
p.51 p.51
Therapeutic Approach
>Prednisone
>Prednisone & azathioprine or cyclophosphamide
>Prednisone & cyclosporine
>Response based on rising Htp.51 -
p.52 p.52
Treating Tissue Hypoxia
>Blood transfusion:
>Ht
>Acuteness of onset
>Clinical signs of hypoxia
>Products:
>Whole blood
>Packed RBC
>Oxyglobin®
>Blood typingp.52 -
p.53 p.53
Image
p.53 -
p.54 p.54
Thromboembolism
>Common cause of mortality
>Poor prognosis if occurs
>Causes:
>Increased procoagulant factors
>Decreased anticoagulant factors
>Vasculitis >Enhanced platelet reactivityp.54 -
p.55 p.55
Thromboembolism (Cont.)
>Contributing factors:
>Icterus
>Catheters
>Therapy:
>Heparin 150-200 units/kg tid-qid
>Aspirin 0.5 mg/kg bid
>Clopidogrel?
>Plasma with concurrent DICp.55 -
p.56 p.56
Supportive Therapy
>Fluids
>Gastric protectants ??
>Specific organ therapyp.56 -
p.57 p.57
SonoPath.com
VETERINARY SONOGRAPHIC DIAGNOSTICSp.57